DE69124416D1 - Wässrige Gelzusammensetzungen und ihre Verwendung - Google Patents

Wässrige Gelzusammensetzungen und ihre Verwendung

Info

Publication number
DE69124416D1
DE69124416D1 DE69124416T DE69124416T DE69124416D1 DE 69124416 D1 DE69124416 D1 DE 69124416D1 DE 69124416 T DE69124416 T DE 69124416T DE 69124416 T DE69124416 T DE 69124416T DE 69124416 D1 DE69124416 D1 DE 69124416D1
Authority
DE
Germany
Prior art keywords
aqueous gel
gel compositions
compositions
aqueous
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69124416T
Other languages
English (en)
Other versions
DE69124416T2 (de
Inventor
Tacey X Viegas
Robert Saul Levinson
Lorraine E Reeve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MDV Technologies Inc
Original Assignee
MDV Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MDV Technologies Inc filed Critical MDV Technologies Inc
Application granted granted Critical
Publication of DE69124416D1 publication Critical patent/DE69124416D1/de
Publication of DE69124416T2 publication Critical patent/DE69124416T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69124416T 1990-05-01 1991-04-24 Wässrige Gelzusammensetzungen und ihre Verwendung Expired - Fee Related DE69124416T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51727390A 1990-05-01 1990-05-01
US51727790A 1990-05-01 1990-05-01
US51728290A 1990-05-01 1990-05-01
US51727890A 1990-05-01 1990-05-01

Publications (2)

Publication Number Publication Date
DE69124416D1 true DE69124416D1 (de) 1997-03-13
DE69124416T2 DE69124416T2 (de) 1997-09-04

Family

ID=27504536

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69124416T Expired - Fee Related DE69124416T2 (de) 1990-05-01 1991-04-24 Wässrige Gelzusammensetzungen und ihre Verwendung

Country Status (5)

Country Link
EP (1) EP0455396B1 (de)
JP (1) JP2753152B2 (de)
CA (1) CA2040460C (de)
DE (1) DE69124416T2 (de)
DK (1) DK0455396T3 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US6436425B1 (en) 1988-11-16 2002-08-20 Mdv Technologies, Inc. Method and non-gelling composition for inhibiting post-surgical adhesions
CA2044878C (en) * 1990-08-07 2000-12-26 Tacey X. Viegas Thermally reversible and irreversible gels
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
SE9301877D0 (sv) * 1993-06-02 1993-06-02 Kabi Pharmacia Ab In situ gel for therapeutic use
WO1994028872A1 (en) * 1993-06-04 1994-12-22 Warner-Lambert Company Non-alcoholic cold and sinus medication
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
JPH09143093A (ja) * 1995-11-17 1997-06-03 Hoechst Japan Ltd 軟骨・骨誘導性修復用材料
SE9601421D0 (sv) * 1996-04-12 1996-04-12 Astra Ab New composition
FR2754712B1 (fr) 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
EP1039932A1 (de) * 1997-12-23 2000-10-04 Alliance Pharmaceutical Corporation Verfahren und zusammensetzungenzur verabreichung pharmazeutischer wirkstoffeund/oder der prävention von adhesion
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8062282B2 (en) 2006-02-13 2011-11-22 Fossa Medical, Inc. Methods and apparatus for temporarily occluding body openings
US20080021068A1 (en) 2006-07-24 2008-01-24 Akorn, Inc. Aqueous gel formulation and method for inducing topical anesthesia
MX2011000545A (es) * 2008-07-14 2011-02-24 Otonomy Inc Composiciones de liberacion controlada para la modulacion de apoptosis y metodos para el tratamiento de trastornos oticos.
KR101367479B1 (ko) * 2008-07-21 2014-03-14 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 귀 질병 치료를 위한 제어 방출형 항미생물성 조성물 및 방법
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US9012477B2 (en) 2009-01-06 2015-04-21 Nuvo Research Inc. Method of treating neuropathic pain
AU2011205730C1 (en) 2010-01-14 2014-10-09 Nuvo Research Inc. Solid-forming local anesthetic formulations for pain control
JP5980304B2 (ja) * 2011-03-21 2016-08-31 博任達生化科技（上海）有限公司Ｂｒｏｄａ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｃｏ．， Ｌｔｄ． 逆熱可逆性のヒドロゲル組成物
ES2760520T3 (es) 2015-07-31 2020-05-14 Univ Warszawski Medyczny Composición de emulsión antipsoriásica que se compone de cefazolina
EP3512513A4 (de) 2016-09-16 2020-04-15 Otonomy, Inc. Gelformulierungen für das ohr zur behandlung von otitis externa

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1554783A (en) * 1976-01-05 1979-10-31 Population Res Inc Pharmaceutical compositions for use in the permanent sterilization of female animals
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4368186A (en) * 1981-05-07 1983-01-11 Syntex (U.S.A.) Inc. Methods and compositions for intravaginal contraception
US4396599A (en) * 1981-09-17 1983-08-02 Johnson & Johnson Products Inc. Anticaries composition
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4474753A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
US4534958A (en) * 1983-07-13 1985-08-13 Basf Wyandotte Corporation Aerosol gel
US4511563A (en) * 1983-07-15 1985-04-16 Basf Wyandotte Corporation Clear analgesic gels with reduced tackiness
DE3428264A1 (de) * 1984-07-27 1986-03-06 Schering Ag Gelhaltige pharmazeutische zubereitungen
JPS61277612A (ja) * 1985-05-31 1986-12-08 Kiyoshi Morikawa 接種用徐放性組成物
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4810503A (en) * 1987-03-31 1989-03-07 Basf Corporation Polymers which form gels at low concentrations in water
US4911926A (en) * 1988-11-16 1990-03-27 Mediventures Inc. Method and composition for reducing postsurgical adhesions

Also Published As

Publication number Publication date
EP0455396A1 (de) 1991-11-06
DE69124416T2 (de) 1997-09-04
JP2753152B2 (ja) 1998-05-18
CA2040460C (en) 1997-06-10
JPH04225914A (ja) 1992-08-14
CA2040460A1 (en) 1991-11-02
EP0455396B1 (de) 1997-01-29
DK0455396T3 (da) 1997-08-11

Similar Documents

Publication Publication Date Title
DE69124416D1 (de) Wässrige Gelzusammensetzungen und ihre Verwendung
DE69637691D1 (de) Azeotropähnliche zusammensetzungen und ihre verwendung
DE69638056D1 (de) Azeotropähnliche zusammensetzungen und ihre verwendung
ATE107130T1 (de) Zusammensetzung und ihre verwendung.
PT85616A (de) Aryloxycarbonsaurederivate ihre herstellung und verwendung
DE10299008I1 (de) Anthelmintische Zusammensetzung und ihre Verwendung
TR199501305A2 (tr) Heterosiklik bilesikler ve bunlarin hazirlanmasi ve kullanimi
DE69413636D1 (de) Reibungsmodifizierende Zusammensetzungen und ihre Verwendung
DE69534265D1 (de) Chimäre zytokine und ihre verwendung
ATA188592A (de) Alkyl-bisacylphosphinoxide, diese enthaltende zusammensetzungen und ihre verwendung
ATE258549T1 (de) Oxazolidindion-derivate, ihre herstellung und verwendung
BR9103582A (pt) Derivados de pirimidina e composicao herbicida
DE69513307D1 (de) Zusammensetzung und verwendung
DE3767400D1 (de) Biozide zusammensetzungen und deren verwendung.
FI972245A0 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
DE69026570D1 (de) Wässrige Polyurethanzusammensetzung und ihre Verwendung
DE69418203D1 (de) Zementiermittel und ihre verwendung
DE69119185D1 (de) Derivate von Carboxymethyl-Chitin und ihre Verwendung
DE69620914D1 (de) Perfluoralkoxycycloalkancarbonylfluorid-zusammensetzungen und ihre verwendung
DE69028579D1 (de) Glas-Metalldichtungen und ihre Anwendung
PT755386E (pt) Derivado de benzamida composicoes contendo o referido derivado e sua utilizacao
DE69333264D1 (de) 3-Phenyl-5-pyridyl-Triazole und ihre Verwendung als Insektizide
DE69100620D1 (de) Schmiermittelzusammensetzung und ihre Verwendung.
DE69332815D1 (de) Polyglyzidyl-Äthern und ihre Verwendung
DE69832902D1 (de) Oromukosal-zytokin-zusammensetzungen und ihre verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee